GLP-1 receptor agonists are peptide-based drugs used for managing diabetes and for weight loss, but these treatments have had shortages recently. Now, through a process called in vivo antibody painting, researchers have attached GLP-1 receptor agonists to antibodies through a reaction that happens inside the body, increasing the drug’s stability. In animal models, a single dose works better and lasts longer than currently administered dosages. The researchers will present their results at ACS Spring 2025.

From laundry detergent to dishwasher tablets, cleaning products are an indispensable part of life. Yet the chemicals that make these products so effective can be difficult to break down or could even trigger ecosystem-altering algal blooms. Now, researchers reporting in ACS’ Langmuir have addressed those challenges with an environmentally compatible detergent made of tiny wood fibers and corn protein that removes stains on clothes and dishes just as well as commercial products.

As of early 2025, tuberculosis cases are increasing in the U.S. This disease, often shortened to TB, causes significant lung damage and, if not treated, is almost always lethal. World TB Day on March 24 raises awareness about the disease and commemorates Robert Koch’s discovery of the source bacterium Mycobacterium tuberculosis. More than a century later, scientists continue refining TB diagnosis methods and treatment strategies, some of which are in these four ACS journal articles.

The American Chemical Society (ACS) is hosting ACS Spring 2025 virtually and in San Diego on March 23-27. Cutting-edge developments on a range of scientific topics will be featured at the meeting. Embargoed press releases and videos about select sessions at the meeting are now available to members of the media.